WuXi AppTec Co., Ltd. (ADR)
General ticker "WUXAY" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $28.8B (TTM average)
WuXi AppTec Co., Ltd. (ADR) follows the US Stock Market performance with the rate: 57.7%.
Estimated limits based on current volatility of 0.8%: low 13.61$, high 13.82$
Factors to consider:
- Earnings expected soon, date: nan
- Company pays dividends (annually): last record date 2025-09-09, amount 0.04$ (Y0.29%)
- Current price 23.4% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.86$, 10.91$]
- 2025-12-31 to 2026-12-31 estimated range: [6.00$, 11.12$]
Financial Metrics affecting the WUXAY estimates:
- Positive: with PPE of 15.8 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 29.51 > 18.38
- Positive: 6.64 < Operating cash flow per share per price, % of 8.28
- Positive: -4.43 < Investing cash flow per share per price, % of -3.68
- Negative: Inventory ratio change, % of 1.59 > 0.80
- Negative: 0.01 < Interest expense per share per price, % of 0.14
- Negative: Shareholder equity ratio, % of 72.99 > 64.29
Short-term WUXAY quotes
Long-term WUXAY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CNY39,354.78MM | CNY40,340.81MM | CNY39,241.43MM |
| Operating Expenses | CNY28,702.53MM | CNY28,468.52MM | CNY27,661.26MM |
| Operating Income | CNY10,652.25MM | CNY11,872.29MM | CNY11,580.17MM |
| Non-Operating Income | CNY-33.77MM | CNY-40.29MM | CNY-40.36MM |
| Interest Expense | CNY159.84MM | CNY74.82MM | CNY216.03MM |
| R&D Expense | CNY1,613.95MM | CNY1,440.63MM | CNY1,238.52MM |
| Income(Loss) | CNY10,618.48MM | CNY11,831.99MM | CNY11,539.81MM |
| Taxes | CNY1,715.87MM | CNY2,131.73MM | CNY1,972.07MM |
| Profit(Loss)* | CNY8,813.71MM | CNY9,606.75MM | CNY9,450.31MM |
| Stockholders Equity | CNY46,589.95MM | CNY55,122.45MM | CNY58,632.71MM |
| Inventory | CNY5,668.59MM | CNY4,736.23MM | CNY5,399.75MM |
| Assets | CNY64,690.33MM | CNY73,669.35MM | CNY80,325.82MM |
| Operating Cash Flow | CNY10,616.03MM | CNY13,386.91MM | CNY12,406.51MM |
| Capital expenditure | CNY9,965.69MM | CNY5,516.56MM | CNY4,003.49MM |
| Investing Cash Flow | CNY-9,690.29MM | CNY-7,560.53MM | CNY-5,518.18MM |
| Financing Cash Flow | CNY-1,277.81MM | CNY-3,941.38MM | CNY-3,832.19MM |
| Earnings Per Share** | CNY3.01 | CNY3.24 | CNY3.26 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.